Next Article in Journal
In Vitro and In Vivo Biological Activities of Cissus adnata (Roxb.)
Next Article in Special Issue
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro
Previous Article in Journal
The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease
Previous Article in Special Issue
Quality Assessment of Platelet-Rich Fibrin-Like Matrix Prepared from Whole Blood Samples after Extended Storage
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessReview
Biomedicines 2017, 5(4), 62;

Muscle–Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies

Pharmaceutical Sciences Department, Université de Bordeaux, BioTis, INSERM Unité 1026, 146 Rue Léo Saignat, 33076 Bordeaux, France
Department for Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri- Kansas City, 650 E 25th St, Kansas City, MO 64108, USA
Author to whom correspondence should be addressed.
Received: 15 September 2017 / Revised: 9 October 2017 / Accepted: 18 October 2017 / Published: 24 October 2017
(This article belongs to the Special Issue Bone Cells and Related Interactions)
Full-Text   |   PDF [4105 KB, uploaded 24 October 2017]   |  


Osteoporosis and sarcopenia are age-related musculoskeletal pathologies that often develop in parallel. Osteoporosis is characterized by a reduced bone mass and an increased fracture risk. Sarcopenia describes muscle wasting with an increasing risk of injuries due to falls. The medical treatment of both diseases costs billions in health care per year. With the impact on public health and economy, and considering the increasing life expectancy of populations, more efficient treatment regimens are sought. The biomechanical interaction between both tissues with muscle acting on bone is well established. Recently, both tissues were also determined as secretory endocrine organs affecting the function of one another. New exciting discoveries on this front are made each year, with novel signaling molecules being discovered and potential controversies being described. While this review does not claim completeness, it will summarize the current knowledge on both the biomechanical and the biochemical link between muscle and bone. The review will highlight the known secreted molecules by both tissues affecting the other and finish with an outlook on novel therapeutics that could emerge from these discoveries. View Full-Text
Keywords: muscle; bone; crosstalk; biomechanical; hormones; therapeutics muscle; bone; crosstalk; biomechanical; hormones; therapeutics

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Maurel, D.B.; Jähn, K.; Lara-Castillo, N. Muscle–Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies. Biomedicines 2017, 5, 62.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top